Ongoing Crestal Bone Loss around Implants Subjected to Computer-Guided Flapless Surgery and Immediate Loading Using the All-on-4® Concept
Related Experiment Video
Updated: May 4, 2026
Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
Hilde Browaeys1, Melissa Dierens2, Christian Ruyffelaert2
1Department of Oral and Maxillofacial Surgery, Dental School, Faculty of Medicine and Health Sciences, University of Ghent, University Hospital Ghent, Ghent, Belgium.
Background:
The All-on-4(®) concept is widely applied for full-arch rehabilitations, using two tilted and two axially loaded implants in order to overcome anatomical constraints.
Purpose:
The aim of this study was to assess the survival and individual success of implants immediately loaded with an All-on-4 full-arch screw-retained prosthetic bridge in fully edentulous mandibles or maxillae over up to 3 years.
Materials And Methods:
In total, 20 patients with atrophic jaws (9 maxillae, 11 mandibles) were treated with computer-guided flapless surgery and immediately provided with a provisional bridge. The final prosthesis was delivered after 6 months. In total, 80 TiUnite(™) Brånemark implants were placed. Radiographs were taken after surgery and 1 and 3 years later.
Results:
A 3-year survival rate of 100% was seen for all implants, both in lower and in upper jaw. None of the temporary or definite prostheses were lost over the follow-up period of 3 years. After 1 year, the mean bone loss was 1.13 mm (SD 0.94; range -0.1 to 3.8), and after 3 years, it was 1.61 mm (SD 1.40; range 0 to 5). The mean bone loss between the 1-year and 3-year follow-ups was 0.48 mm (SD 0.66; range -1.2 to 3.6). This difference was statistically significant (p < .001), indicative of ongoing bone loss. Twenty-six percent of the implants had bone loss above 1.5 mm after 1 year, but after 3 years, 30% of the implants had already lost more than 1.9 mm.
Conclusion:
The implant and prosthetic survival was 100%, and patients benefited from the All-on-4 treatment. However, unacceptable ongoing bone loss was seen in 49.2% of the patients; this may be a warning sign for future problems and needs clinical attention. Overloading and surgery-related aspects need to be investigated as potential explanations.
